Sign In
Buy INSM
$103.86
+0.130 (+0.125%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
11:19am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
12:00am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 29)
• Arvinas Inc (NASDAQ...
Notable earnings before Thursday's open
09:30pm, Wednesday, 29'th Apr 2020
AAL, ABMD, AGIO, AIMC, AIT, AMRN, ARW, ASPS, AUY, BAX, BC, BEN, BPOP, CFR, CG, CHD, CI, CMCSA, COLB, COP, COR, CRS, CWT, DAN, DNKN, DOW, EME, ESI, ETN, FBP, FCN, FLWS, GNRC, GRA, GT, HBI, HGV, HUBB, I
Why Insmed (INSM) Might Surprise This Earnings Season
01:47pm, Wednesday, 29'th Apr 2020
Insmed (INSM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Insmed (INSM) Might Surprise This Earnings Season
01:47pm, Wednesday, 29'th Apr 2020
Insmed (INSM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
08:37pm, Sunday, 26'th Apr 2020
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. Two FDA approvals came through this week, with Immunomedics, Inc.'s
Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
04:32pm, Thursday, 23'rd Apr 2020
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
04:32pm, Thursday, 23'rd Apr 2020
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BRIEF-Brensocatib To Be Studied In Patients With Severe COVID-19 In Investigator-Initiated Trial
10:03am, Thursday, 23'rd Apr 2020
Insmed Inc:
Brensocatib (Formerly INS1007) to be Studied in Patients with Severe COVID-19 in Investigator-Initiated Trial
10:00am, Thursday, 23'rd Apr 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will provide funding and c
Insmed (NASDAQ:INSM) Raised to "Sell" at BidaskClub
09:42am, Thursday, 23'rd Apr 2020
Insmed (NASDAQ:INSM) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Thursday, BidAskClub reports. Severa
Insmed (INSM) to Release Earnings on Thursday
07:42am, Thursday, 23'rd Apr 2020
Insmed (NASDAQ:INSM) will issue its quarterly earnings data before the market opens on Thursday, April 30th. Analysts expect the company to announce earnings of ($0.67) per share for the quarter. Indi
Insmed to Host First Quarter 2020 Financial Results Conference Call on Thursday, April 30, 2020
12:00pm, Monday, 20'th Apr 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its first qua
Cubist Systematic Strategies LLC Has $123,000 Holdings in Insmed Incorporated (NASDAQ:INSM)
10:24am, Saturday, 18'th Apr 2020
Cubist Systematic Strategies LLC lessened its position in shares of Insmed Incorporated (NASDAQ:INSM) by 73.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 5
Bank of America Corp DE Lowers Holdings in Insmed Incorporated (NASDAQ:INSM)
10:24am, Saturday, 18'th Apr 2020
Bank of America Corp DE decreased its position in Insmed Incorporated (NASDAQ:INSM) by 98.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 106,073 sh
